USPTO refuses Drake’s ‘THC’ warning label TM
Canadian singer Drake has failed in his bid to register Canada’s legal cannabis health warning as a US trademark.
In September, Drake’s company DreamCrew filed an application with the US Patent and Trademark Office (USPTO) to register a red, white, and black octagonal design featuring a cannabis leaf and the words, ‘THC’.
Health Canada, the regulatory body which oversees the sale of legal cannabis in the country, requires the logo to be placed on all products containing tetrahydrocannabinol, the main psychoactive ingredient found in the cannabis plant.
The USPTO has now refused registration of the mark, citing a previous mark for ‘THC’ owned by Pineapple Express.
According to the USPTO, Drake’s mark was likely to cause confusion in class 25 for clothing, footwear, and headgear with the Pineapple Express mark, first registered in 1996.
In addition to class 25 for items such as boots, Drake had also filed the mark in classes 5, 31, and 34, covering various herb products.
The USPTO refused registration of the ‘THC’ mark in these classes based on a lack of intent to use the mark lawfully in commerce.
While some states have legalised cannabis for medicinal and recreational use, cannabis remains illegal in the US on a federal level.
It had previously been suggested that Drake would struggle to register the mark as the logo was owned by the Canadian government.
In an email sent to MarketWatch after the original application was filed, Health Canada said the symbol was “protected by crown copyright and intended to be used for public health and safety purposes only and not for private commercial means”.
“It can be an infringement of crown copyright to reproduce the symbol for commercial purposes without permission to do so from the copyright owner,” the statement read.
Did you enjoy reading this story? Sign up to our free daily newsletters and get stories like this sent straight to your inbox.
Today's top stories:
Kylie Minogue decor brand loses copyright claim
Already registered?
Login to your account
If you don't have a login or your access has expired, you will need to purchase a subscription to gain access to this article, including all our online content.
For more information on individual annual subscriptions for full paid access and corporate subscription options please contact us.
To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.
For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk